You are currently viewing this page as a full fledged member! If you would like all pages to display this detail of information and wish to sign up for a membership, please click here
On the heels of a recent upswing in anti-homeopathy activity in Australia, Canada, and the UK, the FDA recently gave surprise notice of its intent to review the legal status of homeopathic products in the U.S. marketplace. The fact that this will be the first such FDA review in twenty-five years makes its timing more than a little suspicious.
Print Options
Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.
